Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey

Health Policy

Volumn 100, Issue 2-3, 2011, Pages 151-158

  Wagner, Anita K ^a   Graves, Amy Johnson ^a   Reiss, Sheila K ^a   LeCates, Robert ^a   Zhang, Fang ^a   Ross Degnan, Dennis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Access to care; Africa; Economic burden; Health insurance; Medicines coverage

Indexed keywords

ARTICLE; ECONOMICS; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SURVEY; HUMAN; RISK FACTOR;

COST OF ILLNESS; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HUMANS; PHARMACEUTICAL PREPARATIONS; REGRESSION ANALYSIS; WORLD HEALTH;

EID: 79954797722     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.08.004     Document Type: Article

References (23)

1. Xu K., Evans D.B., Carrin G., Aguilar-Rivera A.M., Musgrove P., Evans T. Protecting households from catastrophic spending. Health Affairs 2007, 4:972-983. 10.1377/hlthaff.26.4.972.
2. Russell S. Illuminating cases: understanding the economic burden of illness through case study household research. Health Policy and Planning 2005, 20:277-289. 10.1093/heapol/czi035.
3. Xu K., Evans D.B., Kawabata K., Zeramdini R., Klavus J., Murray C.J.L. Household catastrophic health expenditure: a multicountry analysis. Lancet 2003, 362:111-117.
4. Üstün T.B., Chatterji S., Mechbal A., Murray C.J.L. The World Health Surveys. Health systems performance assessment: debates, methods, and empiricism 2003, 797-808. WHS Collaborating Groups, World Health Organization, Geneva. C.J.L. Murray, D.B. Evans (Eds.).
5. World Health Organization World Health Survey 2003, World Health Organization, Geneva, http://www.who.int/healthinfo/survey/en/index.html; [accessed on 1/2010].
6. Electronic data tables by country. URL: www.whoccpp.org; [accessed on 8/25/2010].
7. Xu K. Distribution of health payments and catastrophic expenditures: methodology. Discussion paper EIP/HSF/DP.05.2 2005, World Health Organization, Geneva.
8. Leive A., Xu K. Coping with out-of-pocket health payments: evidence from 15 African countries. Bulletin of the World Health Organization 2008, 86:849-856.
9. Ferguson B.D., Tandon A., Gakidou E., Murray C.J.L. Estimating permanent income using indicator variables. Discussion paper. Evidence and Information Policy Cluster 2003, World Health Organization, Geneva.
10. World Bank country income classification for 2003. ; [accessed on 1/2010]. http://siteresources.worldbank.org/INTRGEP2004/Resources/classification.pdf.
11. Lu C.Y., Ross-Degnan D., Soumerai S.B., Pearson S.A. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature-2001-2007. BMC Health Services Research 2008, 8:75. 10.1186/1472-6963-8-75.
12. Yip W., Hsiao W. Non-evidence-based policy: how effective is China's new cooperative medical scheme in reducing medical impoverishment?. Social Science and Medicine 2009, 68:201-209. 10.1016/j.socscimed.2008.09.066.
13. Van Doorslaer E., O'Donnell O., Rannan-Elyia R., Somanathan A., Adhikari S.R., Garg C.C., et al. Catastrophic payments for health care in Asia. Health Economics 2007, 16:1159-1184. 10.1002/hec.1209.
14. Wagstaff A., Lindelow M. Can insurance increase financial risk? The curious case of health insurance in China. Journal of Health Economics 2008, 27:990-1005. 10.1016/j.jhealeco.2008.02.002.
15. Palmer N., Mills A., Wadee H., Gilson L., Schneider H. A new face for private providers in developing countries: what implications for public health?. Bulletin of the World Health Organization 2002, 80:292-297.
16. Bennett S., Quick J.D., Velásquez G. Public-private roles in the pharmaceutical sector: implications for equitable access and rational drug use. World Health Organization. Health Economics and Drugs Series 1997, (5):1-115.
17. Uganda Ministry of Health. Access to and use of medicines by households in Uganda. Survey conducted in 2008. ; [accessed on 7/12/2010]. http://apps.who.int/medicinedocs/documents/s16374e/s16374e.pdf.
18. Patel A., Gauld R., Norris P., Rades T. This body does not want free medicines" South African consumers' perceptions of drug quality. Health Policy and Planning 2009, 1-9. 10.1093/heapol/czp039.
19. Cameron A., Ewen M., Ross-Degnan D., Ball D., Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009, 373:240-249. 10.1016/S0140-6736(08)61762-6.
20. McIntyre D., Thiede M., Dahlgren G., Whitehead M. What are economic consequences for households of illness and of paying got health care in low- and middle-income country contexts. Social Science & Medicine 2006, 62:858-865.
21. Carrin G., Mathauer I., Xu K., Evans D.B. Universal coverage of health services: tailoring its implementation. Bulletin of the World Health Organization 2008, 86:857-863. 10.2471/BLT.07.049387.
22. Wagner A.K., Valera M., Graves A.J., Laviña S., Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Services Research 2008, 8:161. 10.1186/1472-6963-8-161.
23. Wagner A.K., Ross-Degnan D. The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries. Prescribing cultures and pharmaceutical policy in the Asia-Pacific 2009, 313-335. The Walter H. Shorenstein Asia-Pacific Research Center Press, Stanford, CA. K. Eggleston (Ed.).